OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD8+ T Lymphocyte and NK Cell Network: Circuitry in the Cytotoxic Domain of Immunity
Roman V. Uzhachenko, Anil Shanker
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

NK cells are never alone: crosstalk and communication in tumour microenvironments
Yongqiang Zhou, Cheng Lu, Lu Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 75

Single-cell transcriptome atlas of lung adenocarcinoma featured with ground glass nodules
Tao Lu, Xiaodong Yang, Yu Shi, et al.
Cell Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 77

Modulation of the tumor microenvironment (TME) by melatonin
Mu Qi, Masoud Najafi
European Journal of Pharmacology (2021) Vol. 907, pp. 174365-174365
Closed Access | Times Cited: 68

Distinct transcriptome architectures underlying lupus establishment and exacerbation
M Nakano, Mineto Ota, Yusuke Takeshima, et al.
Cell (2022) Vol. 185, Iss. 18, pp. 3375-3389.e21
Open Access | Times Cited: 66

Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment
Yifei Zhu, Xinyan Li, Lei Wang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 61

Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy
Shweta Joshi, Andrew B. Sharabi
Pharmacology & Therapeutics (2022) Vol. 235, pp. 108114-108114
Open Access | Times Cited: 52

Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation
Wei‐Feng Qu, Meng‐Xin Tian, Hongwei Lü, et al.
Hepatology International (2023) Vol. 17, Iss. 4, pp. 927-941
Open Access | Times Cited: 30

Natural peptides for immunological regulation in cancer therapy: Mechanism, facts and perspectives
Yunchao Zhang, Chenxin Liu, Chunjie Wu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114257-114257
Open Access | Times Cited: 27

Invited review: From heat stress to disease—Immune response and candidate genes involved in cattle thermotolerance
Pauline Lemal, Katharina May, S. König, et al.
Journal of Dairy Science (2023) Vol. 106, Iss. 7, pp. 4471-4488
Open Access | Times Cited: 26

Mechanisms of CD8+ T cell exclusion and dysfunction in cancer resistance to anti-PD-(L)1
Keywan Mortezaee, Jamal Majidpoor
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114824-114824
Open Access | Times Cited: 24

The Role of Microbiota-Derived Vitamins in Immune Homeostasis and Enhancing Cancer Immunotherapy
Hasti Gholami, John A. Chmiel, Jeremy P. Burton, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1300-1300
Open Access | Times Cited: 22

KPC-luciferase-expressing cells elicit an anti-tumor immune response in a mouse model of pancreatic cancer
Daniele Ferrari, Fernanda Ramos-Gomes, Frauke Alves, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8

Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children
Noam D. Beckmann, Phillip Comella, Esther Cheng, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 51

The Interplay of Exosomes and NK Cells in Cancer Biology
Inês A. Batista, Sofia Torres Quintas, Sónia A. Melo
Cancers (2021) Vol. 13, Iss. 3, pp. 473-473
Open Access | Times Cited: 45

(Im)maturity in Tumor Ecosystem
Keywan Mortezaee, Jamal Majidpoor
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 33

Targeting CD8+ T cells with natural products for tumor therapy: Revealing insights into the mechanisms
Yuke Wang, Yan Zeng, Wenyong Yang, et al.
Phytomedicine (2024) Vol. 129, pp. 155608-155608
Closed Access | Times Cited: 7

Downregulated cytotoxic CD8+ T-cell identifies with the NKG2A-soluble HLA-E axis as a predictive biomarker and potential therapeutic target in keloids
Heng Xu, Zhu Zhu, Jian Hu, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 4, pp. 527-539
Open Access | Times Cited: 27

Successful targeting of PD-1/PD-L1 with chimeric antigen receptor-natural killer cells and nivolumab in a humanized mouse cancer model
Wai Nam Liu, Wing Yan So, Sarah Harden, et al.
Science Advances (2022) Vol. 8, Iss. 47
Open Access | Times Cited: 26

Lysosomal peptidases—intriguing roles in cancer progression and neurodegeneration
Janko Kos, Ana Mitrović, Milica Perišić Nanut, et al.
FEBS Open Bio (2022) Vol. 12, Iss. 4, pp. 708-738
Open Access | Times Cited: 23

Microphysiological systems for solid tumor immunotherapy: opportunities and challenges
Sara Abizanda-Campo, Marı́a Virumbrales-Muñoz, Mouhita Humayun, et al.
Microsystems & Nanoengineering (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 15

CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastoma
Guillem Pascual‐Pasto, Brendan McIntyre, Margaret G. Hines, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top